Aethlon Medical Inc Sustainability Reports
Aethlon Medical, Inc. is a clinical-stage medical therapeutic company developing products to treat cancer and life-threatening infectious diseases. Its primary product is the Hemopurifier, an extracorporeal therapeutic device designed to remove tumor-derived extracellular vesicles and enveloped viruses from the bloodstream.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 54930036LMXCIW3XG337
3 reports from 2008 to 2025
Company Profile
Aethlon Medical, Inc. is a clinical-stage medical therapeutic company developing products to treat cancer and life-threatening infectious diseases. Its primary product is the Hemopurifier, an extracorporeal therapeutic device designed to remove tumor-derived extracellular vesicles and enveloped viruses from the bloodstream.
Reports
3 total
Limited sustainability disclosure available
This company only publishes Annual Reports without dedicated sustainability sections.
